Last reviewed · How we verify

NCT04123132

Evaluation of Kinesophobia in Patients With Metabolic Syndrome

Status unknown Last updated 10 January 2020
What this trial tests

trial testing Kinesiophobia in Kinesiophobia in 96 participants. Status unknown.

Timeline
25 September 2019
Primary endpoint
1 February 2020
1 February 2020

Quick facts

Lead sponsorErol Olcok Corum Training and Research Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment96
Start date25 September 2019
Primary completion1 February 2020
Estimated completion1 February 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Erol Olcok Corum Training and Research Hospital

Who can join

Adults 45 to 65, any sex, with Kinesiophobia or Metabolic Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Metabolic syndrome (MS) is a public health problem characterized by central obesity, increased blood pressure and triglyceride levels, decreased blood HDL levels and the presence of insulin resistance (1).Kinesiophobia is a fear of irrational movement that develops because of its belief in susceptibility to injury and is associated with low levels of physical activity. Considering that exercise improves metabolic processes in people with MS, we aimed to evaluate the presence of kinesophobia in patients with MS. Patients aged 45-65 years diagnosed with metabolic syndrome and healthy controls will be included in the study. Patients with rheumatic and neurological diseases,history of trauma, gonarthrosis, lumbar disc hernia, previous fractures, fibromyalgia and those who have experienced pain for the last week will be excluded. The participants will be filled in the Short Form-36 (SF-36), the Hospital Anxiety and Depression Scale, and the Tampa Kinesiophobia Scale. 48 patients with MS and 48 healthy participants will be included in the study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Kinesiophobia

Currently open trials in the same condition.

Other Erol Olcok Corum Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04123132.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing